Table 5. Treatment and outcome of patients with PC.
| Initially treatment methods | Immunocompetent patients (n=53) | Immunocompromised patients (n=35) | |||||||
|---|---|---|---|---|---|---|---|---|---|
| CR | PR | NC | PD | CR | PR | NC | PD | ||
| Clinical observation | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | |
| Antifugal drugs | |||||||||
| Fluconazole | 10 | 7 | 2 | 1 | 5 | 2 | 1 | 1 | |
| Itraconzole | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | |
| Voriconzole | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | |
| Drugs combination | 4 | 3 | 1 | 1 | 5 | 2 | 1 | 1 | |
| Fluconazole + 5-fluorocytosine | 3 | 2 | 1 | 1 | 1 | 0 | 1 | 0 | |
| AmBd + 5-fluorocytosine | 1 | 1 | 0 | 0 | 4 | 2 | 0 | 1 | |
| Surgery | 9 | 0 | 0 | 0 | 5 | 0 | 0 | 0 | |
| Pulmonary wedged excisions | 6 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | |
| Lobectomy | 3 | 0 | 0 | 0 | 2 | 0 | 0 | 0 | |
| Surgery + antifungal drugs | 5 | 0 | 0 | 0 | 6 | 0 | 1 | 0 | |
| Pulmonary wedged excisions+ antifungal drugs | 2 | 0 | 0 | 0 | 3 | 0 | 1 | 0 | |
| Lobectomy + antifungal drugs | 3 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | |